Michael Egholm - 20 Nov 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
President & CEO, Director
Signature
/s/ Michael Egholm by Agnieszka Gallagher, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
20 Nov 2024
Transactions value $
-$43,480
Form type
4
Filing time
21 Nov 2024, 20:55:41 UTC
Previous filing
05 Sep 2024
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Tax liability -$43.5K -28.8K -1.92% $1.51 1.47M 20 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 21, 2024.